Cargando…

Ketone bodies: from enemy to friend and guardian angel

ABSTRACT: During starvation, fasting, or a diet containing little digestible carbohydrates, the circulating insulin levels are decreased. This promotes lipolysis, and the breakdown of fat becomes the major source of energy. The hepatic energy metabolism is regulated so that under these circumstances...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolb, Hubert, Kempf, Kerstin, Röhling, Martin, Lenzen-Schulte, Martina, Schloot, Nanette C., Martin, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656040/
https://www.ncbi.nlm.nih.gov/pubmed/34879839
http://dx.doi.org/10.1186/s12916-021-02185-0
_version_ 1784612201731981312
author Kolb, Hubert
Kempf, Kerstin
Röhling, Martin
Lenzen-Schulte, Martina
Schloot, Nanette C.
Martin, Stephan
author_facet Kolb, Hubert
Kempf, Kerstin
Röhling, Martin
Lenzen-Schulte, Martina
Schloot, Nanette C.
Martin, Stephan
author_sort Kolb, Hubert
collection PubMed
description ABSTRACT: During starvation, fasting, or a diet containing little digestible carbohydrates, the circulating insulin levels are decreased. This promotes lipolysis, and the breakdown of fat becomes the major source of energy. The hepatic energy metabolism is regulated so that under these circumstances, ketone bodies are generated from β-oxidation of fatty acids and secreted as ancillary fuel, in addition to gluconeogenesis. Increased plasma levels of ketone bodies thus indicate a dietary shortage of carbohydrates. Ketone bodies not only serve as fuel but also promote resistance to oxidative and inflammatory stress, and there is a decrease in anabolic insulin-dependent energy expenditure. It has been suggested that the beneficial non-metabolic actions of ketone bodies on organ functions are mediated by them acting as a ligand to specific cellular targets. We propose here a major role of a different pathway initiated by the induction of oxidative stress in the mitochondria during increased ketolysis. Oxidative stress induced by ketone body metabolism is beneficial in the long term because it initiates an adaptive (hormetic) response characterized by the activation of the master regulators of cell-protective mechanism, nuclear factor erythroid 2-related factor 2 (Nrf2), sirtuins, and AMP-activated kinase. This results in resolving oxidative stress, by the upregulation of anti-oxidative and anti-inflammatory activities, improved mitochondrial function and growth, DNA repair, and autophagy. In the heart, the adaptive response to enhanced ketolysis improves resistance to damage after ischemic insults or to cardiotoxic actions of doxorubicin. Sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors may also exert their cardioprotective action via increasing ketone body levels and ketolysis. We conclude that the increased synthesis and use of ketone bodies as ancillary fuel during periods of deficient food supply and low insulin levels causes oxidative stress in the mitochondria and that the latter initiates a protective (hormetic) response which allows cells to cope with increased oxidative stress and lower energy availability. KEYWORDS: Ketogenic diet, Ketone bodies, Beta hydroxybutyrate, Insulin, Obesity, Type 2 diabetes, Inflammation, Oxidative stress, Cardiovascular disease, SGLT2, Hormesis
format Online
Article
Text
id pubmed-8656040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86560402021-12-10 Ketone bodies: from enemy to friend and guardian angel Kolb, Hubert Kempf, Kerstin Röhling, Martin Lenzen-Schulte, Martina Schloot, Nanette C. Martin, Stephan BMC Med Review ABSTRACT: During starvation, fasting, or a diet containing little digestible carbohydrates, the circulating insulin levels are decreased. This promotes lipolysis, and the breakdown of fat becomes the major source of energy. The hepatic energy metabolism is regulated so that under these circumstances, ketone bodies are generated from β-oxidation of fatty acids and secreted as ancillary fuel, in addition to gluconeogenesis. Increased plasma levels of ketone bodies thus indicate a dietary shortage of carbohydrates. Ketone bodies not only serve as fuel but also promote resistance to oxidative and inflammatory stress, and there is a decrease in anabolic insulin-dependent energy expenditure. It has been suggested that the beneficial non-metabolic actions of ketone bodies on organ functions are mediated by them acting as a ligand to specific cellular targets. We propose here a major role of a different pathway initiated by the induction of oxidative stress in the mitochondria during increased ketolysis. Oxidative stress induced by ketone body metabolism is beneficial in the long term because it initiates an adaptive (hormetic) response characterized by the activation of the master regulators of cell-protective mechanism, nuclear factor erythroid 2-related factor 2 (Nrf2), sirtuins, and AMP-activated kinase. This results in resolving oxidative stress, by the upregulation of anti-oxidative and anti-inflammatory activities, improved mitochondrial function and growth, DNA repair, and autophagy. In the heart, the adaptive response to enhanced ketolysis improves resistance to damage after ischemic insults or to cardiotoxic actions of doxorubicin. Sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors may also exert their cardioprotective action via increasing ketone body levels and ketolysis. We conclude that the increased synthesis and use of ketone bodies as ancillary fuel during periods of deficient food supply and low insulin levels causes oxidative stress in the mitochondria and that the latter initiates a protective (hormetic) response which allows cells to cope with increased oxidative stress and lower energy availability. KEYWORDS: Ketogenic diet, Ketone bodies, Beta hydroxybutyrate, Insulin, Obesity, Type 2 diabetes, Inflammation, Oxidative stress, Cardiovascular disease, SGLT2, Hormesis BioMed Central 2021-12-09 /pmc/articles/PMC8656040/ /pubmed/34879839 http://dx.doi.org/10.1186/s12916-021-02185-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Kolb, Hubert
Kempf, Kerstin
Röhling, Martin
Lenzen-Schulte, Martina
Schloot, Nanette C.
Martin, Stephan
Ketone bodies: from enemy to friend and guardian angel
title Ketone bodies: from enemy to friend and guardian angel
title_full Ketone bodies: from enemy to friend and guardian angel
title_fullStr Ketone bodies: from enemy to friend and guardian angel
title_full_unstemmed Ketone bodies: from enemy to friend and guardian angel
title_short Ketone bodies: from enemy to friend and guardian angel
title_sort ketone bodies: from enemy to friend and guardian angel
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656040/
https://www.ncbi.nlm.nih.gov/pubmed/34879839
http://dx.doi.org/10.1186/s12916-021-02185-0
work_keys_str_mv AT kolbhubert ketonebodiesfromenemytofriendandguardianangel
AT kempfkerstin ketonebodiesfromenemytofriendandguardianangel
AT rohlingmartin ketonebodiesfromenemytofriendandguardianangel
AT lenzenschultemartina ketonebodiesfromenemytofriendandguardianangel
AT schlootnanettec ketonebodiesfromenemytofriendandguardianangel
AT martinstephan ketonebodiesfromenemytofriendandguardianangel